Company Encyclopedia
View More
name
Materialise
MTLS.US
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers.
2.707 T
MTLS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Application SoftwareIndustry
Industry Ranking132/254
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.78%C
    • Profit Margin1.68%C
    • Gross Margin56.82%B
  • Growth ScoreC
    • Revenue YoY0.99%C
    • Net Profit YoY-54.69%D
    • Total Assets YoY10.58%B
    • Net Assets YoY6.89%B
  • Cash ScoreB
    • Cash Flow Margin5942.84%A
    • OCF YoY0.99%C
  • Operating ScoreB
    • Turnover0.65B
  • Debt ScoreB
    • Gearing Ratio39.50%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Materialise Lists On Euronext Brussels

    Nov 20 (Reuters) - Materialise NV:* LISTS ON EURONEXT BRUSSELS Source text: Further company coverage:(Gdansk Newsroom)((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Reuters·
    US
    MTLS
    -1.32%
    Reuters·
    US
    MTLS
    -1.32%

    Materialise NV Announces Updated Issued Shares and Voting Rights

    Materialise NV announced its shares are now trading on Euronext Brussels, with a total capital of €4,487,050.49. The company has 59,067,186 shares carrying 90,712,021 voting rights. This follows compliance with Belgian transparency regulations for its listing.

    Reuters·
    US
    MTLS
    -1.32%
    Reuters·
    US
    MTLS
    -1.32%

    European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading

    European equities traded in the US as American depositary receipts fell sharply, with the S&P Europe Select ADR Index down 1.40% to 1,577.43. Notable gainers included Materialise and DBV Technologies, while significant decliners were Genfit and trivago. From the UK and Ireland, Trinity Biotech and Amarin led gains, whereas Biodexa Pharmaceuticals and Autolus Therapeutics saw major declines. The report highlights fluctuations in stock performance across various sectors.

    fidelity·
    US
    DBVT
    +0.46%
    US
    MTLS
    -1.32%
    fidelity·
    US
    DBVT
    +0.46%
    US
    MTLS
    -1.32%

    Materialise NV Announces Results of 2025 Extraordinary Shareholders' Meeting

    Leuven, Belgium, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Materialise NV ( NASDAQ: MTLS ) , a leading provider of additive manufacturing software and of sophisticated 3D printing solutions, today announced the results of the votes cast at its Extraordinary Shareholders' Meeting, where all the ...

    GlobeNewswire·
    US
    MTLS
    -1.32%
    GlobeNewswire·
    US
    MTLS
    -1.32%

    European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

    European equities traded in the US as American depositary receipts declined 0.93% on Friday, reaching 1,612.91 on the S&P Europe Select ADR Index. Ascendis Pharma and Cellectis led gainers from continental Europe, while EDAP TMS and Materialise led decliners. In the UK and Ireland, Akari Therapeutics and Autolus Therapeutics were top gainers, while NuCana and Endava were top decliners. The index is up 0.57% for the week.

    fidelity·
    US
    EDAP
    -0.62%
    US
    MTLS
    -1.32%
    fidelity·
    US
    EDAP
    -0.62%
    US
    MTLS
    -1.32%
    © 2025 Longbridge｜Disclaimer